Inion Appoints Mr Julien Cotta as Chief Financial Officer

24-Apr-2006 - Inion announced that Julien Cotta has been appointed as Chief Financial Officer and executive member of the Company's Board of Directors. Mr Cotta will take up his duties in June 2006. Since gaining his qualification as a Chartered Accountant from Coopers & Lybrand (now PriceWaterhouseCoopers) ...

Inion receives Patent Grant for Biotech Application of a Genetically Modified Variant of Bone Morphogenetic Protein

First biotech patent resulting from programme to develop next-generation bioactive biomaterials

04-Apr-2006 - Inion announced the granting of a patent covering a genetically modified form of the bone morphogenetic protein BMP-4, which prevents the abnormal formation of bone in extra-skeletal tissues. This patent (No. 116827) has been granted in Finland and is issued in the US. Bone morphogenetic proteins ...

Inion Signs Three-Year Development Agreement with University of Cambridge

Collaboration with Medical Materials Group to extend next-generation bioactive materials platform

14-Nov-2005 - Inion has entered into a three-year collaboration agreement with The Cambridge Centre for Medical Materials at the University of Cambridge Department of Materials Science & Metallurgy. The collaboration will focus on developing a new medical materials platform combining the proprietary Inion ...

Inion Signs Exclusive US Distribution Agreement for its Sports Medicine Product Range with Richard Wolf Medical Instruments Corp

28-Oct-2005 - Inion announced that it has entered into an exclusive agreement with Richard Wolf Medical Instruments Corporation for the distribution of the Inion Sports Medicine range of biodegradable medical devices. Richard Wolf is a global leader in endoscopic diagnosis and therapy systems in the field of ...

SA SpineVision litigation dismissed by French Commercial Court

21-Oct-2005 - Inion Oy has successfully defended a court action brought by SA SpineVision in the Commercial Court of Paris. Inion and SpineVision signed a confidentiality agreement in October 2002 with a view to exploring the possibilities of a joint development in the spinal area. However, no contractual ...

Inion introduces its First Biodegradable Spinal Implant in Europe

CE Mark received for S-1TM Anterior Cervical Fixation System

18-Aug-2005 - Inion has received a CE Mark for the S-1TM Anterior Cervical Fixation System for spinal applications. CE Mark is required by a number of accredited bodies to medical device manufacturers prior to commercial distribution in the European Union. S-1TM is a biodegradable anterior cervical fusion ...

Inion Wins Euro 1.9m Grant Funding to Develop OPTIMAPLUS(tm) Bioactive and Biodegradable Materials Platform

09-Aug-2005 - Inion has secured a Euro 1.9m grant from the Finnish Technology funding body TEKES. The matching grant will be used to fund 50% of a three-year Euro 3.8m project as part of the Company's development plans for its next-generation materials technology OPTIMAPLUSTM. The remaining half will be funded ...